Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13933 | 804 | 39.8 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
54 | 3 | ASTHMA//RESPIRATORY SYSTEM//ALLERGY | 90590 |
2444 | 2 | DRY POWDER INHALER//PULMONARY DELIVERY//PULMONARY DRUG DELIVERY | 4061 |
13933 | 1 | INHALED INSULIN//PULMONARY ABSORPTION//CALU 3 | 804 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INHALED INSULIN | authKW | 1871603 | 8% | 79% | 62 |
2 | PULMONARY ABSORPTION | authKW | 1198607 | 7% | 60% | 53 |
3 | CALU 3 | authKW | 325679 | 3% | 32% | 27 |
4 | EXUBERA | authKW | 303823 | 1% | 100% | 8 |
5 | EXUBERA R | authKW | 265845 | 1% | 100% | 7 |
6 | PULMONARY DELIVERY | authKW | 247949 | 6% | 14% | 46 |
7 | PULMONARY DRUG DISPOSITION | authKW | 220958 | 1% | 73% | 8 |
8 | CALU 3 CELLS | authKW | 183418 | 2% | 30% | 16 |
9 | PULMONARY DRUG DELIVERY | authKW | 175497 | 4% | 13% | 35 |
10 | CALU 3 CELL LINE | authKW | 158240 | 1% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 6653 | 53% | 0% | 425 |
2 | Endocrinology & Metabolism | 1351 | 17% | 0% | 134 |
3 | Respiratory System | 1035 | 10% | 0% | 79 |
4 | Chemistry, Multidisciplinary | 387 | 17% | 0% | 134 |
5 | Chemistry, Medicinal | 360 | 7% | 0% | 56 |
6 | Medicine, General & Internal | 81 | 6% | 0% | 51 |
7 | Medicine, Research & Experimental | 78 | 5% | 0% | 39 |
8 | Critical Care Medicine | 21 | 1% | 0% | 11 |
9 | Public, Environmental & Occupational Health | 19 | 3% | 0% | 28 |
10 | Physiology | 16 | 3% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TA PAIN CONTROL | 113934 | 0% | 100% | 3 |
2 | PHARMACEUT THER EUT | 65869 | 1% | 14% | 12 |
3 | RD CELL TISSUE BASED SYST | 50636 | 0% | 67% | 2 |
4 | BIOPHARMACEUT PHARMACEUT TECHNOL | 49384 | 2% | 7% | 18 |
5 | ARTMENT PULM MED TB | 37978 | 0% | 100% | 1 |
6 | BIOINORGAN CHEM INORGAN DRUGS | 37978 | 0% | 100% | 1 |
7 | BIOPHARM SOLUT | 37978 | 0% | 100% | 1 |
8 | BIOPHARRNACEUT PHARMACEUT TECHNOL | 37978 | 0% | 100% | 1 |
9 | CANC INFECT IMED | 37978 | 0% | 100% | 1 |
10 | CLIN HEART THORAX VASC SURG | 37978 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG | 36469 | 3% | 4% | 25 |
2 | DIABETES TECHNOLOGY & THERAPEUTICS | 30800 | 4% | 2% | 33 |
3 | PHARMACEUTICAL RESEARCH | 21298 | 8% | 1% | 67 |
4 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 6895 | 3% | 1% | 26 |
5 | JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 6298 | 1% | 2% | 8 |
6 | DIABETES CARE | 4277 | 4% | 0% | 36 |
7 | JOURNAL OF PHARMACEUTICAL SCIENCES | 4110 | 4% | 0% | 35 |
8 | ADVANCED DRUG DELIVERY REVIEWS | 3614 | 2% | 1% | 16 |
9 | EXPERT OPINION ON DRUG DELIVERY | 3530 | 1% | 1% | 10 |
10 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 3415 | 5% | 0% | 38 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INHALED INSULIN | 1871603 | 8% | 79% | 62 | Search INHALED+INSULIN | Search INHALED+INSULIN |
2 | PULMONARY ABSORPTION | 1198607 | 7% | 60% | 53 | Search PULMONARY+ABSORPTION | Search PULMONARY+ABSORPTION |
3 | CALU 3 | 325679 | 3% | 32% | 27 | Search CALU+3 | Search CALU+3 |
4 | EXUBERA | 303823 | 1% | 100% | 8 | Search EXUBERA | Search EXUBERA |
5 | EXUBERA R | 265845 | 1% | 100% | 7 | Search EXUBERA+R | Search EXUBERA+R |
6 | PULMONARY DELIVERY | 247949 | 6% | 14% | 46 | Search PULMONARY+DELIVERY | Search PULMONARY+DELIVERY |
7 | PULMONARY DRUG DISPOSITION | 220958 | 1% | 73% | 8 | Search PULMONARY+DRUG+DISPOSITION | Search PULMONARY+DRUG+DISPOSITION |
8 | CALU 3 CELLS | 183418 | 2% | 30% | 16 | Search CALU+3+CELLS | Search CALU+3+CELLS |
9 | PULMONARY DRUG DELIVERY | 175497 | 4% | 13% | 35 | Search PULMONARY+DRUG+DELIVERY | Search PULMONARY+DRUG+DELIVERY |
10 | CALU 3 CELL LINE | 158240 | 1% | 83% | 5 | Search CALU+3+CELL+LINE | Search CALU+3+CELL+LINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SAKAGAMI, M , (2006) IN VIVO, IN VITRO AND EX VIVO MODELS TO ASSESS PULMONARY ABSORPTION AND DISPOSITION OF INHALED THERAPEUTICS FOR SYSTEMIC DELIVERY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 58. ISSUE 9-10. P. 1030-1060 | 76 | 60% | 148 |
2 | SIEKMEIER, R , SCHEUCH, G , (2008) INHALED INSULIN - DOES IT BECOME REALITY?.JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 59. ISSUE . P. 81 -113 | 66 | 73% | 45 |
3 | ARNOLDS, S , HEISE, T , (2007) INHALED INSULIN.BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 21. ISSUE 4. P. 555-571 | 47 | 76% | 9 |
4 | CAVAIOLA, TS , EDELMAN, S , (2014) INHALED INSULIN: A BREATH OF FRESH AIR? A REVIEW OF INHALED INSULIN.CLINICAL THERAPEUTICS. VOL. 36. ISSUE 8. P. 1275 -1289 | 25 | 93% | 19 |
5 | BECQUEMIN, MH , CHAUMUZEAU, JP , (2008) INHALED INSULIN: A MODEL FOR PULMONARY SYSTEMIC ABSORPTION?.REVUE DES MALADIES RESPIRATOIRES. VOL. 25. ISSUE 2. P. 209-222 | 45 | 68% | 1 |
6 | AGU, RU , UGWOKE, MI , ARMAND, M , KINGET, R , VERBEKE, N , (2001) THE LUNG AS A ROUTE FOR SYSTEMIC DELIVERY OF THERAPEUTIC PROTEINS AND PEPTIDES.RESPIRATORY RESEARCH. VOL. 2. ISSUE 4. P. 198-209 | 39 | 75% | 170 |
7 | SOARES, S , COSTA, A , SARMENTO, B , (2012) NOVEL NON- INVASIVE METHODS OF INSULIN DELIVERY.EXPERT OPINION ON DRUG DELIVERY. VOL. 9. ISSUE 12. P. 1539 -1558 | 39 | 63% | 16 |
8 | KUGLER, AJ , FABBIO, KL , PHAM, DQ , NADEAU, DA , (2015) INHALED TECHNOSPHERE INSULIN: A NOVEL DELIVERY SYSTEM AND FORMULATION FOR THE TREATMENT OF TYPES 1 AND 2 DIABETES MELLITUS.PHARMACOTHERAPY. VOL. 35. ISSUE 3. P. 298 -314 | 24 | 89% | 6 |
9 | RASHID, J , ABSAR, S , NAHAR, K , GUPTA, N , AHSAN, F , (2015) NEWER DEVICES AND IMPROVED FORMULATIONS OF INHALED INSULIN.EXPERT OPINION ON DRUG DELIVERY. VOL. 12. ISSUE 6. P. 917 -928 | 32 | 67% | 3 |
10 | SIEKMEIER, R , SCHEUCH, G , (2009) TREATMENT OF SYSTEMIC DISEASES BY INHALATION OF BIOMOLECULE AEROSOLS.JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY. VOL. 60. ISSUE . P. 15-26 | 47 | 50% | 14 |
Classes with closest relation at Level 1 |